Leland Gershell
Stock Analyst at Oppenheimer
(4.23)
# 1,489
Out of 4,988 analysts
732
Total ratings
40.3%
Success rate
7.6%
Average return
Main Sectors:
Stocks Rated by Leland Gershell
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Reiterated: Buy | $262 → $312 | $236.72 | +31.80% | 38 | Sep 2, 2026 | |
| CAPR Capricor Therapeutics | Upgraded: Buy | $54 | $9.06 | +496.03% | 28 | Aug 25, 2026 | |
| SPRB Spruce Biosciences | Reiterated: Buy | $230 | $53.05 | +333.55% | 6 | Aug 25, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,037 → $1,100 | $990.32 | +11.08% | 19 | Aug 18, 2026 | |
| EQ Equillium | Rated: Buy | $7 | $1.92 | +264.58% | 4 | Aug 14, 2026 | |
| OKUR OnKure Therapeutics | Reiterated: Buy | $30 → $14 | $2.95 | +374.58% | 3 | Aug 14, 2026 | |
| PALI Palisade Bio | Reiterated: Buy | $8 | $1.59 | +403.14% | 2 | Aug 11, 2026 | |
| BMRN BioMarin Pharmaceutical | Rated: Buy | $98 → $97 | $63.94 | +51.70% | 39 | Aug 7, 2026 | |
| CLYM Climb Bio | Reiterated: Buy | $18 | $14.05 | +28.11% | 6 | Aug 7, 2026 | |
| IMVT Immunovant | Reiterated: Buy | $54 | $36.95 | +46.14% | 9 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $326 | $283.49 | +15.00% | 4 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $25 | $14.95 | +67.22% | 18 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $60 | $43.25 | +38.73% | 48 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.91 | - | 8 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.76 | - | 2 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $3.51 | +298.86% | 7 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $28 | $3.55 | +688.73% | 21 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.92 | +420.83% | 16 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.06 | +843.40% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $22.00 | - | 34 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $4.20 | +376.19% | 3 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $21 | $5.38 | +290.33% | 2 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $2.41 | +937.34% | 44 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $37.05 | - | 7 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2,000 | $29.48 | +6,684.26% | 4 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $8.20 | +119.51% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $97.71 | - | 6 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.49 | +60.64% | 3 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $16.57 | +111.23% | 28 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80 | $27.00 | n/a | 1 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $490 | $239.56 | n/a | 42 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $1.34 | n/a | 20 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $38.98 | n/a | 10 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $106 | $68.78 | n/a | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $0.8055 | n/a | 19 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.58 | n/a | 17 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $0.9158 | n/a | 19 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.11 | n/a | 16 | Jul 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.35 | n/a | 6 | Oct 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $0.1288 | n/a | 11 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $200 | $0.000001 | n/a | 11 | Mar 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.48 | n/a | 16 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $0.0003 | n/a | 1 | Jun 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $0.47756 | n/a | 11 | Jun 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $1.00 | n/a | 16 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $2.61 | n/a | 7 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0112 | n/a | 4 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.11 | n/a | 22 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.63 | n/a | 13 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.6526 | n/a | 9 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0074 | n/a | 15 | Sep 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.13 | n/a | 3 | May 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.16 | n/a | 9 | May 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.11 | n/a | 9 | Apr 3, 2019 |
Ascendis Pharma
Sep 2, 2026
Reiterated: Buy
Price Target: $262 → $312
Current: $236.72
Upside: +31.80%
Capricor Therapeutics
Aug 25, 2026
Upgraded: Buy
Price Target: $54
Current: $9.06
Upside: +496.03%
Spruce Biosciences
Aug 25, 2026
Reiterated: Buy
Price Target: $230
Current: $53.05
Upside: +333.55%
argenx SE
Aug 18, 2026
Reiterated: Buy
Price Target: $1,037 → $1,100
Current: $990.32
Upside: +11.08%
Equillium
Aug 14, 2026
Rated: Buy
Price Target: $7
Current: $1.92
Upside: +264.58%
OnKure Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $30 → $14
Current: $2.95
Upside: +374.58%
Palisade Bio
Aug 11, 2026
Reiterated: Buy
Price Target: $8
Current: $1.59
Upside: +403.14%
BioMarin Pharmaceutical
Aug 7, 2026
Rated: Buy
Price Target: $98 → $97
Current: $63.94
Upside: +51.70%
Climb Bio
Aug 7, 2026
Reiterated: Buy
Price Target: $18
Current: $14.05
Upside: +28.11%
Immunovant
Aug 7, 2026
Reiterated: Buy
Price Target: $54
Current: $36.95
Upside: +46.14%
Aug 7, 2026
Reiterated: Buy
Price Target: $326
Current: $283.49
Upside: +15.00%
Aug 7, 2026
Reiterated: Buy
Price Target: $24 → $25
Current: $14.95
Upside: +67.22%
Aug 6, 2026
Reiterated: Buy
Price Target: $50 → $60
Current: $43.25
Upside: +38.73%
Jun 22, 2026
Rated: Hold
Price Target: n/a
Current: $1.91
Upside: -
Jun 22, 2026
Rated: Hold
Price Target: n/a
Current: $3.76
Upside: -
Jun 15, 2026
Reiterated: Buy
Price Target: $14
Current: $3.51
Upside: +298.86%
May 20, 2026
Reiterated: Buy
Price Target: $25 → $28
Current: $3.55
Upside: +688.73%
May 15, 2026
Reiterated: Buy
Price Target: $10
Current: $1.92
Upside: +420.83%
May 6, 2026
Reiterated: Buy
Price Target: $10
Current: $1.06
Upside: +843.40%
Apr 13, 2026
Rated: Hold
Price Target: n/a
Current: $22.00
Upside: -
Mar 31, 2026
Reiterated: Buy
Price Target: $20
Current: $4.20
Upside: +376.19%
Feb 27, 2026
Reiterated: Buy
Price Target: $35 → $21
Current: $5.38
Upside: +290.33%
Feb 12, 2026
Reiterated: Buy
Price Target: $25
Current: $2.41
Upside: +937.34%
Feb 10, 2026
Rated: Hold
Price Target: n/a
Current: $37.05
Upside: -
Nov 14, 2025
Reiterated: Buy
Price Target: $2,000
Current: $29.48
Upside: +6,684.26%
Nov 7, 2025
Reiterated: Buy
Price Target: $18
Current: $8.20
Upside: +119.51%
Nov 4, 2025
Downgraded: Hold
Price Target: n/a
Current: $97.71
Upside: -
Oct 14, 2025
Reiterated: Buy
Price Target: $4
Current: $2.49
Upside: +60.64%
Sep 29, 2025
Reiterated: Buy
Price Target: $35
Current: $16.57
Upside: +111.23%
Sep 3, 2025
Initiated Coverage: Buy
Price Target: $80
Current: $27.00
Upside: n/a
Aug 4, 2025
Upgraded: Buy
Price Target: $490
Current: $239.56
Upside: n/a
Sep 16, 2024
Reiterated: Buy
Price Target: $25
Current: $1.34
Upside: n/a
May 20, 2024
Rated: Hold
Price Target: n/a
Current: $38.98
Upside: n/a
May 14, 2024
Reiterated: Buy
Price Target: $106
Current: $68.78
Upside: n/a
Mar 28, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $0.8055
Upside: n/a
Dec 18, 2023
Reiterated: Buy
Price Target: n/a
Current: $3.58
Upside: n/a
Nov 13, 2023
Reiterated: Buy
Price Target: $11
Current: $0.9158
Upside: n/a
Jul 10, 2023
Reiterated: Buy
Price Target: n/a
Current: $2.11
Upside: n/a
Oct 4, 2022
Downgraded: Hold
Price Target: n/a
Current: $4.35
Upside: n/a
May 26, 2022
Reiterated: Buy
Price Target: $60
Current: $0.1288
Upside: n/a
Mar 21, 2022
Reiterated: Buy
Price Target: $70 → $200
Current: $0.000001
Upside: n/a
Nov 16, 2021
Reiterated: Hold
Price Target: n/a
Current: $7.48
Upside: n/a
Jun 4, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $0.0003
Upside: n/a
Jun 2, 2021
Rated: Buy
Price Target: $12
Current: $0.47756
Upside: n/a
May 18, 2021
Rated: Buy
Price Target: $7
Current: $1.00
Upside: n/a
May 7, 2021
Initiated Coverage: Buy
Price Target: $42
Current: $2.61
Upside: n/a
May 6, 2021
Reiterated: Hold
Price Target: n/a
Current: $0.0112
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $9.11
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $13.63
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $0.6526
Upside: n/a
Sep 11, 2020
Rated: Hold
Price Target: n/a
Current: $0.0074
Upside: n/a
May 10, 2019
Reiterated: Buy
Price Target: $7
Current: $1.13
Upside: n/a
May 9, 2019
Rated: Hold
Price Target: n/a
Current: $1.16
Upside: n/a
Apr 3, 2019
Reiterated: Buy
Price Target: $8
Current: $3.11
Upside: n/a